Equity Overview
Price & Market Data
Price: $6.63
Daily Change: $0.00 / 0.00%
Daily Range: $0 - $0
Market Cap: $425,317,600
Daily Volume: 0
Performance Metrics
1 Week: 6.94%
1 Month: 18.39%
3 Months: 27.99%
6 Months: 9.59%
1 Year: 20.11%
YTD: 21.65%
Company Details
Employees: 113
Sector: Health technology
Industry: Biotechnology
Country: United States
Details
Aura Biosciences, Inc., a clinical-stage biotechnology company, develops precision therapies to treat solid tumors. The company's proprietary platform enables the targeting of a range of solid tumors using virus-like particles conjugated with drugs or loaded with nucleic acids to create virus-like drug conjugates. Its lead candidate is bel-sar, which is in late-stage clinical development for the treatment of patients with primary choroidal melanoma and other ocular oncology indications, as well as in early-stage clinical development in bladder cancer. It focuses on assessing the safety and efficacy of bel-sar in treating a range of other solid tumors, including bladder cancer. The company was incorporated in 2009 and is headquartered in Boston, Massachusetts.